SG3 Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-770,500
Closed -$6.44M 305
2022
Q2
$6.44M Buy
770,500
+120,500
+19% +$1.68M 0.76% 29
2022
Q1
$14.9M Buy
650,000
+543,000
+507% +$13.3M 0.42% 46
2021
Q4
$2.95M Buy
107,000
+67,000
+168% +$1.79M 0.06% 268
2021
Q3
$1.11M Sell
40,000
-50,000
-56% -$1.42M 0.03% 441
2021
Q2
$2.64M Buy
+90,000
New +$2.73M 0.09% 246
2017
Q2
Sell
-50,000
Closed -$552K 219
2017
Q1
$552K Sell
50,000
-20,000
-29% -$275K 0.1% 129
2016
Q4
$1.02M Buy
+70,000
New +$1.28M 0.16% 96

Other funds holding BHC

SG3 Management's BHC Position: Q3 2022 in Review

SG3 Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 770,500 shares — an estimated $5.35M sold.

SG3 Management first reported a position in BHC in Q1 2021 and held it in 6 quarters. The position peaked at $37.9M in Q1 2022. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • SG3 Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • SG3 Management sold 770,500 Bausch Health shares in Q3 2022, an estimated $5.35M.
  • SG3 Management first reported a position in Bausch Health in Q1 2021 and held it in 6 quarters.
  • SG3 Management's Bausch Health position peaked at $37.9M in Q1 2022.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.